Chemotherapy in Small Cell Lung Cancer with End-Stage Renal Disease on Hemodialysis / 이화의대지
The Ewha Medical Journal
;
: S5-S9, 2014.
Artículo
en Coreano
| WPRIM
| ID: wpr-126668
ABSTRACT
Small cell lung cancer is primarily treated with chemotherapy. For patients with end-stage renal disease (ESRD), systemic chemotherapy is often challenging since renal excretion of chemotherapeutic agents might be decreased due to impaired renal function, leading to increased toxicity. No consensus is made so far regarding appropriate dosage and combination of chemotherapeutic agents for patients on hemodialysis. We report two cases of chemotherapy without significant toxicity in small cell lung cancer patients who were on hemodialysis for ESRD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Diálisis Renal
/
Consenso
/
Quimioterapia
/
Carcinoma Pulmonar de Células Pequeñas
/
Fallo Renal Crónico
Tipo de estudio:
Guía de Práctica Clínica
Límite:
Humanos
Idioma:
Coreano
Revista:
The Ewha Medical Journal
Año:
2014
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS